Patrys strengthens development case for blood cancer drug W
Publicado: Jue Mar 21, 2013 10:01 am
Patrys strengthens development case for blood cancer drug
Wednesday, March 20, 2013 by Angela Kean
Cita:
"Patrys (ASX: PAB) has reported further preclinical data that strongly supports the ongoing clinical development of the company’s lead anti-cancer drug, PAT-SM6, in the treatment of blood cancer, multiple myeloma.."
Leer mas en:
http://www.proactiveinvestors.com.au/co ... 41019.html
(en el caso de no entender el articulo por estar redactado en inglés:
http://translate.google.es/?hl=es#en/es/
Wednesday, March 20, 2013 by Angela Kean
Cita:
"Patrys (ASX: PAB) has reported further preclinical data that strongly supports the ongoing clinical development of the company’s lead anti-cancer drug, PAT-SM6, in the treatment of blood cancer, multiple myeloma.."
Leer mas en:
http://www.proactiveinvestors.com.au/co ... 41019.html
(en el caso de no entender el articulo por estar redactado en inglés:
http://translate.google.es/?hl=es#en/es/